Ables Iannone Moore & Associates’s Humana HUM Stock Holding History
Bought
Maintained
Sold
Other funds holding HUM
DSA
Ables Iannone Moore & Associates's HUM Position: Q1 2024 in Review
Ables Iannone Moore & Associates sold out of Humana (HUM) in Q1 2024, closing a stake of 2 shares — an estimated $916 sold.
Ables Iannone Moore & Associates first reported a position in HUM in Q4 2023 and held it in 1 quarter. The position peaked at $916 in Q4 2023. 1,029 funds tracked by Wall St. Rank hold HUM as of Q1 2024.
- Ables Iannone Moore & Associates reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
- Ables Iannone Moore & Associates sold 2 Humana shares in Q1 2024, an estimated $916.
- Ables Iannone Moore & Associates first reported a position in Humana in Q4 2023 and held it in 1 quarter.
- Ables Iannone Moore & Associates's Humana position peaked at $916 in Q4 2023.
- 1,029 funds tracked by Wall St. Rank held Humana as of Q1 2024.
Based on Ables Iannone Moore & Associates's 13F filing for Q1 2024, filed 30 Apr 2024.